Skip to main content
. Author manuscript; available in PMC: 2011 May 10.
Published in final edited form as: Liver Transpl. 2000 Nov;6(6):686–702. doi: 10.1053/jlts.2000.19029

Figure 1.

Figure 1

Fraction of CD45+ cells (leukocytes) that were CD11b/c+ (myeloid precursor–derived) in the cell suspensions of control (group 0) and transplanted LEW isografts (group 1) and allografts (groups 2 through 6) after 5 and 100 days’ residence in the host. Note the low CD11b/c representation at day 5 in the BMC-primed group 5 and the liver-primed group 6. At day 100, the CD11b/c fraction remained low in these groups, and it had been reduced in group 3 after discontinuance of TAC.